Zhitong Financial App News, Zhongzhi Pharmaceutical (03737.HK) announced that since November 6, 2026, Mr. Kan Siu-lin, M.H., has been appointed as an independent non-executive director of the company, as well as members of the Audit Committee, Remuneration Committee and Nomination Committee. Mr. Zhou Daihan has resigned as an independent non-executive director of the company as well as a member of the Audit Committee, Remuneration Committee and Nomination Committee.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.